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Abstract
African horse sickness is an economically highly important non-contagious but infectious Orbivirus disease that is
transmitted by various species of Culicoides midges. The equids most severely affected by the virus are horses,
ponies, and European donkeys; mules are somewhat less susceptible, and African donkeys and zebra are refractory
to the devastating consequences of infection. In recent years, Bluetongue virus, an Orbivirus similar to African horse
sickness, which also utilises Culicoides spp. as its vector, has drastically increased its range into previously unaffected
regions in northern Europe, utilising indigenous vector species, and causing widespread economic damage to the
agricultural sector. Considering these events, the current review outlines the history of African horse sickness,
including information concerning virus structure, transmission, viraemia, overwintering ability, and the potential
implications that an outbreak would have for Ireland. While the current risk for the introduction of African horse
sickness to Ireland is considered at worst ‘very low’, it is important to note that prior to the 2006 outbreak of
Bluetongue in northern Europe, both diseases were considered to be of equal risk to the United Kingdom
(‘medium-risk’). It is therefore likely that any outbreak of this disease would have serious socio-economic
consequences for Ireland due to the high density of vulnerable equids and the prevalence of Culicoides species,
potentially capable of vectoring the virus.
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Introduction
African horse sickness (AHS) is a disease caused by the
African horse sickness virus (AHSV). The disease affects
horses, ponies, and European donkeys most severely;
mules are somewhat less affected, and African donkeys
and zebra are refractory to the devastating consequences
of infection [1-4]. The virus is a non-contagious, vector-
borne Orbivirus that is transmitted primarily by female
Culicoides midges during a blood meal, which they re-
quire for reproduction [4]. In addition to equids, camels,
goats, and buffalo can become infected [5]. Additionally,
some carnivores such as dogs, can become infected via
ingestion of contaminated meat. However, there have
been no documented cases of transmission of AHSV in
carnivores in the wild, and it is considered that they are
a ‘dead-end’ host, rather than a reservoir of infection
[6,7]. Owing to the potential of this virus to cause
widespread death and debilitating disease in naïve equid
populations, it is listed as a notifiable equine disease by
the World Organisation for Animal Health (OIE), which
makes outbreaks of the disease compulsorily notifiable to
the OIE. Such occurrences can result in serious conse-
quences for international trade of animals and animal
products for the affected country [8]. It is currently pre-
dicted, that a widespread outbreak of this disease would
have a devastating effect on the horse industry of any
country affected [9].
History
The first recorded reference of AHS occurred in 1327 in
Yemen [10], but it is most likely that the virus originated
on the African continent where it could have been trans-
mitted in the natural zebra population [2]. The disease
was first recognised around 60 years after the initial
introduction of horses to Africa in 1657, and the first
major outbreak occurred in 1719. This outbreak resulted
in the deaths of approximately 1, 700 animals [11]. Sub-
sequently, there has been at least an additional 10 major
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http://www.irishvetjournal.org/content/65/1/9(and several lesser) outbreaks of AHS on the African
continent [2]. These outbreaks typically coincide with
warm-phase El niňo southern oscillation (ENSO) events
[12] and they have had devastating results for the African
horse population, most notably, the 1854–1855 outbreak
in South Africa, which resulted in the deaths of around
70, 000 animals [13,14]. Throughout the last century,
there has been a steady decline in the number of cases of
AHS in South Africa, which correlated with a decline in
the number of wild zebra due to hunting. Currently,
AHS is not considered to be endemic in the greater part
of South Africa, with the exception of the North-eastern
Lowveld of Mpumalanga Province where seroconversion
of AHSV occurs in zebra in every month of the year and
virtually all adult animals have specific antibodies to all
nine serotypes of the virus. Typically, the disease first
appears in the North-eastern part of the country in De-
cember/January and subsequently spreads southwards, oc-
casionally reaching as far as the Western Cape Province
[14]. However, it has been reported that restocking of zebra
is occurring in many areas of South Africa and that at
some point, conditions for the re-establishment for AHS in
other regions of the country may occur [2]. These condi-
tions appear to have been reached in recent years, with a
number of outbreaks of AHSV serotype 1 (AHSV-1)
recorded in the Western Cape Province, with a horse case
fatality rate of more than 90% [15].
While AHS is considered to be primarily an African
disease, there have been a number of epizootic events
that have occurred outside this region. The most severe
of which occurred in Asia between 1959–1961, when AHSV
s e r o t y p e9( A H S V - 9 )s p r e a dt h r o u g h o u tA f g h a n i s t a n ,
Cyprus, India, Iraq, Jordan, Lebanon, Pakistan, Saudi Ara-
bia, and Syria resulting in the deaths of around 300, 000
equids [2,3,16-18]. This outbreak was followed by another
epizootic of AHSV-9 in 1965 which spread throughout
Morocco, Algeria, Tunisia and Spain. It is believed that the
movement of nomads and their donkeys across the Sahara
was responsible the appearance of AHSV-9 in northern
Africa [2].
Following these outbreaks, AHS was confined to sub-
Saharan Africa for around 20 years until July 1987, when
AHSV serotype 4 (AHSV-4) was reported in central
Spain [19]. This serotype had never before been recorded
outside of Africa [20], and it is believed that the outbreak
was caused by the importation of a number of sub-clinically
infected zebra from Namibia to a safari park at Aldea del
Fresno [19]. This site subsequently became the foci for the
first 27 cases of AHS in Europe [21]. Over the following
months, the outbreaks continued to spread within central
Spain until October, when temperatures became too low
for the virus transmission cycle to continue. It was initially
hoped that this break in the transmission cycle would re-
move the infection from the region, but this was not the
case, and AHSV successfully overwintered in the European
climate. Subsequently, new outbreaks occurred in Spain
(1988–1990), Portugal (1989) and Morocco (1989–1991)
[20] indicating that the virus had persisted in the area for at
least five years and successfully overwintered on four occa-
sions. In total, the outbreak in Spain resulted in the deaths
of over 400 equids, and a further 900 were destroyed in
attempts to control the virus spread. It was not until 1990,
when a monovalent vaccine was administered to more than
350, 000 susceptible animals, that the outbreak was con-
trolled [20,22]. Portugal reported a total of 206 cases, but
here the infection was removed quickly following a mass
vaccination policy, eradication on infected farms, and strict
animal movement controls. The total cost of the 13-week
incursion into Portugal was estimated at around US $ 2
million [23]. While this figure may seem high compared to
the total number of deaths (US $ 9, 493/mortality), when
compared to the Portuguese equine population as a whole,
the total cost of this campaign appears relatively small (170,
000 animals, US $ 11.50/animal). This campaign must
therefore be seen as successful, as it drastically reduced the
potential damage to the Portuguese equine industry [23].
The African horse sickness virus
There are currently nine recognised serotypes of AHSV
worldwide, the last of which was identified in 1960 [24].
The AHSV is a double-stranded RNA virus from the
genus Orbivirus (family Reoviridae), and as such, it is
morphologically similar to other Orbiviruses such as
Bluetongue virus (BTV), Epizootic haemorrhagic disease
virus (EHDV), and Equine encephalosis virus (EEV)
[1,7,25,26]. The virion, which is approximately 70 nm in
diameter, is made up of a two-layered icosahedral capsid
[13]. This capsid encloses the genome which comprises
ten segments of linear double stranded RNA [26,27].
The outer shell of the capsid comprises two structural
proteins (VP2 and VP5), which are involved in virus at-
tachment and cell entry. These are the most variable
proteins and as such are used to determine the virus
serotype (usually VP2) [4,28-31].
Pathogenesis
Despite the distinct differences in the clinical severity of
AHS infection in different equids, the typical pattern of
pathogenesis is similar. Following exposure through the
bite of an infected vector, the virus initially replicates in
an adjacent lymph node before disseminating throughout
the entire body via the circulatory system. This is the pri-
mary viraemia which leads to infection of the lungs and
lymphoid tissues. The virus then undergoes a further
replication cycle in these target organs which in turn
gives rise to a secondary viraemia. The virus has a predi-
lection for the vascular endothelial cells throughout the
body, causing extensive damage including effusions into
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[13]. The duration of this process from initial infection
to secondary viraemia can vary between 2–21 days, al-
though it usually takes less than nine [32]. In horses, the
period of viraemia usually lasts between 4–8 days,
whereas in donkeys, it may persist for up to four weeks.
In zebra, this period may be extended to approximately
40 days post-infection [4,13,18,33]. In common with
BTV, AHSV is often associated with red blood cells of
the infected animal throughout both primary and sec-
ondary viraemia. In ruminants infected with BTV, this
often leads to an extended period of viraemia, although
this does not appear to be the case with AHS [2].
Clinical signs
AHSV displays itself in the form of four diseases: cardiac
form, pulmonary form, mixed form, and horse sickness
fever [34].
The cardiac form of the disease is usually characterised
by the development of a fever, oedema of the head, neck,
chest, supraorbital fossae, petechial haemorrhages in the
eyes (Figure 1), ecchymotic haemorrhages on the tongue,
and colic. In these cases, mortality of infected animals
may exceed 50% [13].
The pulmonary form of the disease is the most serious.
It is typically associated with a rapid onset of symptoms
which include the development of a fever, depression, se-
vere respiratory distress (Figure 2), severe dyspnoea,
coughing, and sweating. Typically, the mortality rates of
this form of the disease exceed 95% [13].
The mixed form is often the most common form of
the disease and as the name suggests, it is a combination
of the cardiac and the pulmonary form. Typically, the
mortality rate may exceed 70%, and death can often
occur within three to six days [13].
Horse sickness fever is the mildest form of the disease,
during which, the animal will develop a moderate fever
and some oedema of the supraorbital fossae (Figure 3).
There is no mortality associated with this form of the
disease [13].
The African horse sickness vector
The principal vector of AHSV is the female midge of the
genus Culicoides (Diptera: Ceratopogonidae). These
insects are important vectors of a number of viral diseases
worldwide including: Akabane, Bovine ephemeral fever,
Bluetongue, Epizootic haemorrhagic disease, Equine ence-
phalosis, Oropouche, and The Palyams [1,35]. It was first
discovered that adult females from the genus Culicoides
were the principal vector for AHSV in 1944 [36]. Today
there are approximately 1, 340 recognised species of Culi-
coides worldwide, of which 96% are obligate bloodsuckers
[37]. Typically, Culicoides spp. measure between 1–3m m ,
making them amongst the smallest haematophagous
flies in the world, and they are currently found on all
Figure 1 Horse suffering from petechial haemorrhage. Picture
courtesy of the Institute for Animal Health, Pirbright.
Figure 2 Horse suffering from severe respiratory distress.
Picture courtesy of the Institute for Animal Health, Pirbright.
Figure 3 Horse exhibiting oedema of the supraorbital fossae.
Picture courtesy of the Institute for Animal Health, Pirbright.
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4, 200 m (in Tibet) [38].
The principal vector of AHSV worldwide is Culicoides
imicola [39], which is a common species distributed
throughout Africa, much of Southeast Asia, and south-
ern Europe [2]. It has been reported that over 1 million
individuals may be captured in a single light trap per
night [40]. It was previously considered that C. imicola
was the only species of Culicoides capable of vectoring
AHSV, but other species have been identified as potential
vectors. A laboratory study in 1975 found that the
American BTV vector, Culicoides variipennis (sonoren-
sis), also has the ability to transmit AHSV [41]. Addition-
ally, AHSV has also been isolated from the northern
European BTV vectors, Culicoides obsoletus and Culi-
coides pulicaris, during the AHSV-4 outbreak in Spain
[42,43]. However, it is important to note that the pres-
ence of virus does not necessarily indicate that these
midges are capable of virus transmission. More recently,
Culicoides bolitinos has been implicated as a vector in
Africa, particularly at higher altitudes where C. imicola is
rare [44,45].
While Culicoides spp. are widely considered to be the
principal vector for the transmission of AHSV, a number
of other species have been implicated in its transmission.
Laboratory experiments have shown that some species
of mosquito, most notably Aedes aegypti, Anopheles ste-
phensi, and Culex pipiens, are capable of AHSV infection
and transmission [4,41,46-49]. Although, the virus only
underwent multiplication in a limited number of mos-
quitoes and the maximum virus titre was not appreciably
higher than the amounts ingested, an eclipse phase oc-
curred subsequent to infection and virus was recovered
for at least five weeks [41]. Additionally, AHSV has also
been isolated in the field from samples of camel ticks,
Hyalomma dromadarii, in Egypt [50]. However, the pre-
vailing scientific opinion suggests that the role of these
species in the transmission of AHSV is likely to be insig-
nificant [4].
Overwintering
Throughout the majority of the geographic range of
AHSV, the climate is suitable for vector activity and viral
replication to occur throughout the year [4]. For ex-
ample, in northeast South Africa it has been found that
seroconversion of AHSV occurs in every month of the
year in zebra [2]. However, in some regions, conditions
are not suitable for year round vector activity or viral
replication, and a break in the transmission cycle occurs
e.g. Spain (1987–1990). This poses the question as to
where and how does the virus survive over the winter
period? Similar to BTV, there are a number of possible
mechanisms by which AHSV could be overwintering
(Figure 4): 1) in the vector population, 2) in the host
population, 3) via an alternative transmission cycle in-
volving an unknown vector or host [4].
Figure 4 The normal transmission cycle of African horse sickness virus in summer (Left) and possible overwintering mechanisms
(Right). Image created using Microsoft Clip Art with permission from Microsoft PowerPoint (2007).
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There are two possible means by which AHSV may survive
the winter in the adult vector population. The first is via
transovarial transmission (vertical transmission of AHSV
from adult females to their eggs). While there is evidence
that vertical transmission of arboviruses occurs in mosqui-
toes and sandflies [35,51,52], to date, no evidence of live
AHSV has been recovered in any larval Culicoides spp..
Hitherto, only fragments of BTV RNA have been found in
larvae and further research is required in order to fully
understand if this route of transmission exists [53].
A second, better understood method, involves virus re-
tention in adult Culicoides which survive the winter drop
in temperatures. Culicoides imicola activity has been
recorded at temperatures as low as 12°C [54,55]. At these
temperatures, the life span of some Culicoides spp. can
be extend up to 90 days [55,56]. While viral replication
ceases at temperatures below 15°C, once temperatures
raise above this point, viral replication may resume in a
number of individuals [55]. Under these circumstances,
AHSV may overwinter within the adult vector popula-
tion, provided some infected individuals survive through
the winter period. This mechanism was implicated in the
successful overwintering of AHSV in Spain, Portugal,
and Morocco [39,57].
2) Survival in the vertebrate host
While the survival of AHSV in adult Culicoides spp.
remains a better understood mechanism for virus over-
wintering, there are a number of possible means by which
the virus may overwinter within the vertebrate host.
Whilst persistent or chronic infection in horses is consid-
ered unlikely as the period of viraemia is short (4–8 days)
and the mortality rates are high (often>95%) [13], don-
keys may remain viraemic for up to four weeks, and the
viraemic period of zebra can extend up to around 40 days
[4,13,18,33]. This creates the possibility that chronically
infected animals may represent a possible mechanism for
overwintering of AHSV, although there is no current field
evidence to support this hypothesis [4].
Another recently discovered overwintering mechanism
for Orbiviruses is the possibility of vertical transmission
within the host. To date, there has been no evidence to
suggest that this route occurs for AHSV, but recent stud-
ies involving BTV-8 in northern Europe have demon-
strated that this mechanism occurs within cattle [58],
and it may be possible that it also occurs for AHSV, al-
though further research is required to establish if this
mechanism exists.
3) Survival in an unknown vector or host
The final mechanism by which AHSV may be overwin-
tering, is in a vector species other than Culicoides such
as ticks, which can live for several years, easily bridging
the winter gap [59]. It has long been known that AHSV
has been isolated in the field from samples of camel ticks,
Hyalomma dromadarii [50], and a number of experiments
have shown that some species of mosquito are capable of
AHSV infection and transmission [4,46-49]. However, the
prevailing scientific opinion suggests that the role of these
species in the overwintering of AHSV is likely to be negli-
gible [4], and further research is required to evaluate what
role, if any these species play.
Implications for Ireland
The Republic of Ireland (R.O.I.) has a longstanding
equine tradition, and it is therefore unsurprising that it
has the highest density of sport horses in Europe [60]. A
recent estimate valuated the industry in excess of € 1.1
billion per annum [61]. The current national equid
population is estimated at approximately 110, 000 ani-
mals and it is believed that 53, 000 people are regularly
involved in horse riding activities [60]. A conservative
figure of the annual expenditure within the industry is
estimated at approximately € 400 million [60], while the
value of various racing festivals and other meetings to
the local economy was valued at € 260 million [61].
Similarly, in Northern Ireland (N.I.), it is estimated that
around £ 110 million is spent per annum on equine ser-
vices and products within the economy, with a further £
2 million expended outside of N.I. on thoroughbred stud
fees. In total, the equid population is estimated at ap-
proximately 36, 000 animals with a value of around £
108 million. The sector uses approximately 30, 000 acres
of land (> 1% of total agricultural land in N.I.), and is an
important employer within N.I. with the core equine in-
dustry supporting 5, 657 full-time equivalents, equating
to a labour value of around £ 54 million. In addition, the
capital value of buildings and major equipment is esti-
mated at approximately £ 121 million, with the two race
courses at Down Royal and Downpatrick generating ap-
proximately £ 1.7 million per annum in sales revenue
[62].
Whilst any incursion of AHSV into Ireland is likely to
be relatively short lived due to the absence of any suitable
reservoir host, even an isolated case, where infection is
successfully contained, could result in serious economic
consequences due to long-term restrictions on trade. Fur-
thermore, in the event of a widespread outbreak, the direct
loss of horses combined with the introduction of move-
ment restrictions, could have a potentially devastating
effect on the industry. It is estimated that over half the
economic impact of the sector could be lost within one to
two years, with irreparable damage caused to the horse
racing sector and other sporting disciplines [9].
There are three main pathways by which AHS could
be introduced to Ireland: importation of infected equi-
dae, introduction of infected vectors, and importation of
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843 horses imported into R.O.I. in 2009 and 2010, only
four originated from a country where AHS had been
reported (South Africa) [63]. Due to the strict controls
on the export of horses and their products from this re-
gion, a qualitative risk assessment predicted that the risk
of introduce AHSV via this route was ‘very low’[63]. The
same report predicted that the risk of introduction of
AHSV via wind dispersal of infected vectors was cur-
rently ‘negligible’ due to the fact that AHSV has not been
recognised in any country neighbouring Ireland. How-
ever, previous evidence has shown that Culicoides can be
transported up to 700 km via wind dispersal and this
was the most likely transmission route for the introduc-
tion of AHSV into Cyprus (1960), Spain (1966), and the
Cape Verde Islands (1943 & 1999) [64,65]. Furthermore,
this method is seen as the most likely route for the intro-
duction of Bluetongue and more recently, Schmallenberg
virus into the U.K. from mainland Europe [66,67]. This
‘negligible’ status should therefore be revised in the event
of any outbreak being reported in a country of close
proximity. Additionally, the report considered the risk of
AHSV introduction via the accidental importation of
infected Culicoides by ‘hitch-hiking’ on trucks transporting
livestock or plants to be ‘negligible’ as there is no evidence
in the literature to suggest that such accidental transporta-
tion has ever occurred. Finally, the report considered that
the risk of AHSV importation in germplasm/biological
substances was ‘negligible’,a sh i t h e r t ot h e r eh a sb e e nn o
recorded outbreak of AHS due to the use of infected
semen, ova, or embryos [63]. Overall, the current pre-
dicted risk of AHSV to the U.K. and Ireland is considered
‘negligible’ to ‘very low’ [63,68]. Nonetheless, it is impor-
tant to note that these reports did not consider the intro-
duction of AHSV via the illegal importation of infected
equidae and/or their products. Furthermore, the predicted
risk of an incursion of AHSV or BTV into the U.K. prior
to the 2006 BT outbreak was considered to be of
‘Medium-risk’[69]. However, outbreaks of BTV have sub-
sequently been reported in the U.K. in 2007 [70] and in N.
I. in 2008 [58]. For these reasons, and in consideration of
the recent unexplained outbreaks of BTV-8 in northern
Europe [71], it is important that Ireland is suitably pre-
pared should AHSV be imported into the island.
In response to the outbreak of BTV in northern Eur-
ope, the BTV vector surveillance programme was
initiated in Ireland [72]. This programme examined the
activity of Culicoides spp. for one night per week at 34
farmland trapping sites throughout the year. In total, ap-
proximately half a million midges, from 21 species of Culi-
coides were identified. The maximum number of Culicoides
caught in one night was in excess of 21,000 midges in the
R.O.I. [72]. A similar surveillance network in N.I. operating
at 14 trapping sites caught a maximum of around 36,000
Culicoides per night in N.I. [Dr. Stephen Jess, unpublished
observations]. Of the Culicoides identified, approximately
73% were considered to be potential AHSV vectors (Obso-
letus group, 50.6%; Pulicaris group 22%) [72]. Initial results
indicate that the vector period appears to operate between
the beginning of April until mid-November/early Decem-
ber, although midge abundance correlates with weather
conditions, most notably wind and temperature [72]. There-
fore, it is evident that if AHSV were to be introduced into
Ireland there are sufficient vectors present to enable the
spread of the virus.
Conclusions
It is evident from previous outbreaks of AHSV world-
wide that this disease can have serious consequences for
animal health and mortality. As such, it is likely that any
introduction to Ireland would be catastrophic, consider-
ing the high population density of vulnerable animals,
and the importance of the equine industry to the rural
economy. Despite the current risk of importation of
AHSV being considered at worst ‘very low’, a stockpile of
live, attenuated vaccines, which are currently used in
sub-Saharan Africa, has been created for the potential
use in the European Union should an outbreak occur [9].
These vaccines are not currently considered to be an op-
tion for Ireland, as there may be a risk of the vaccine
reverting to the wild-type virus, causing virulence and
spreading the disease [9]. However, DEFRA has recently
initiated a three year project with the aim of developing
a safer and more effective vaccine against AHSV [73].
Consequently, there is an important need for continued
vigilance in Ireland with regard to arthropod-borne dis-
eases such as AHSV and BTV in order to protect live-
stock, the agricultural industry, and the rural economy
as a whole.
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